Concepedia

Thomas Nachreiner

TN

Statistics

Publications

10

Citations

259

H-Index

10

Active since

2008

Affiliations

RWTH Aachen University(Current)

Fraunhofer Institute for Molecular Biology and Applied Ecology

University of Cape Town

Forschungszentrum Jülich

University Medical Center Groningen

Thomas Nachreiner is an author at RWTH Aachen University specializing in oncology, medicine, and targeted cancer therapy.

ORCID

Publications per year

2008–2016

10

Publications

10

Site-Specific, Covalent Labeling of Recombinant Antibody Fragments via Fusion to an Engineered Version of 6-<i>O</i>-Alkylguanine DNA Alkyltransferase

Florian Kampmeier, Markus Ribbert, Thomas Nachreiner et al. · Bioconjugate Chemistry · 2009 · 55 citations

, , +17

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham et al. · Cancer Letters · 2016 · 43 citations

, , +13

A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein

Manal Amoury, Radoslav Mladenov, Thomas Nachreiner et al. · International Journal of Cancer · 2016 · 34 citations · Full text

, , +14

Films that Work. Industrial film and the productivity of media

Thomas Nachreiner · Historical Journal Of Film Radio and Television · 2010 · 25 citations

, , +12

Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin

Thomas Nachreiner, Florian Kampmeier, Theo Thepen et al. · Journal of Neuroimmunology · 2008 · 24 citations

, , +16

1–5 of 10